Participated · Seed · May 2019

Gero develops an AI-driven drug discovery platform that applies physics-based modelling and generative AI to identify mechanisms and targets underlying ageing and multiple chronic conditions. The platform leverages longitudinal data from approximately 10 million medical records to inform target discovery. Gero is advancing programs aimed at slowing ageing and is supporting those programs through preclinical development. The company has pharmaceutical partnerships including a collaboration with Roche’s Chugai that featured an upfront payment and up to $250 million in milestones, and an alliance with Pfizer. Financially, Gero has now raised $17 million in its most recent round, bringing total equity funding to $34 million. The company is based in Singapore.

Participated · Seed · Jan 2019

Wannaby builds AR commerce experiences and has launched a beta of Wanna Kicks, an iOS app that lets users virtually try on sneakers by pointing their camera at their feet. The app uses 3D geometry algorithms and neural networks to identify shoe position and tracks feet as users move; Wannaby creates bespoke 3D models in its own studio. The company is working on additional features such as mirror-facing mode and video sharing. Wannaby positions the product to help retailers and customers by increasing online conversions and reducing returns. It targets Gen Z and millennial sneaker buyers and emphasizes AR as a marketing and discovery tool. CEO Sergey Arkhangelskiy, an ex-Googler, leads the company, which has raised seed funding to support its product and modeling work.